Alec McDonald

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh et al. · The Lancet · 2017 · 1.9K citations · Full text

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

R.D. James, Rob Glynne‐Jones, Helen Meadows et al. · The Lancet Oncology · 2013 · 711 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +8

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

Somnath Mukherjee, John Bridgewater, Stephen Falk et al. · The Lancet Oncology · 2013 · 345 citations · Full text

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer

Andrew Crumley, Donald C. McMillan, Margaret McKernan et al. · British Journal of Cancer · 2006 · 283 citations · Full text

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma

Robert Jones, Eftychia‐Eirini Psarelli, Richard Jackson et al. · JAMA Surgery · 2019 · 256 citations · Full text